Market closedNon-fractional

Immatics/IMTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Immatics

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Ticker

IMTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Tübingen, Germany

Employees

484

Immatics Metrics

BasicAdvanced
$1.3B
Market cap
-
P/E ratio
-$1.01
EPS
0.69
Beta
-
Dividend rate
$1.3B
0.69
3.946
3.794
2.963
3.653
-10.76%
-26.73%
13.245
3.14
3.15
-37.264
-6.59%
-3.96%
33.05%
-39.03%

What the Analysts think about Immatics

Analyst Ratings

Majority rating from 8 analysts.
Buy

Immatics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-9.93% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€30M
89.94%
Net income
-€3M
-88.51%
Profit margin
-9.93%
-93.95%

Immatics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 85.58%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-€0.32
-€0.32
-€0.30
-€0.03
-
Expected
-€0.25
-€0.36
-€0.32
-€0.21
-€0.28
Surprise
30.08%
-11.52%
-7.08%
-85.58%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Immatics stock?

Immatics (IMTX) has a market cap of $1.3B as of July 23, 2024.

What is the P/E ratio for Immatics stock?

The price to earnings (P/E) ratio for Immatics (IMTX) stock is 0 as of July 23, 2024.

Does Immatics stock pay dividends?

No, Immatics (IMTX) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Immatics dividend payment date?

Immatics (IMTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Immatics?

Immatics (IMTX) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Immatics stock

Buy or sell Immatics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing